The Drug Security Forum will be held on the opening day of the St. Petersburg International Economic Forum. Its business programme will include expert discussions on the Russian pharmaceutical industry’s growth strategies and the role of those strategies in ensuring national drug security.
The COVID-19 pandemic has highlighted the issue of national drug security and has given a new perspective to the development strategies of the Russian pharmaceutical industry. Import independence and innovation are key to strengthening Russia’s pharmaceutical industry. The country must also develop a domestic active pharmaceutical ingredient (API) manufacturing network and create conditions that foster innovation in the Russian pharmaceutical industry. Not only will supporting domestic pharmaceutical lifecycle management and shifting the regulatory focus from expanding generic product portfolios to launching a complete range of domestic innovative preparations bolster national drug security, it will also increase the competitiveness of the Russian pharmaceutical industry, raising it to the rank of global market leader.
“The pharmaceutical industry support measures implemented in the Russian Federation over the last several years have taken operations to the next level. The Russian pharmaceutical industry has proven that it can operate effectively and without interruptions, even during a pandemic. The drugs that we are developing and manufacturing are not only satisfying domestic market demand, they are also showing promising export potential,” said Aleksander Petrov, Chairman of the Subcommittee on the Circulation of Medicines and Pharmaceutical and Medical Industry Development, part of the Committee on Health Protection of the State Duma of the Russian Federation.
Participants of the session ‘Growth Strategy of the Russian Pharma Industry as a Basis of National Drug Security’, will discuss the regulatory solutions and government incentives Russia needs to create a new, competitive API manufacturing industry, the government support and regulatory instruments with the potential to stimulate innovation in the Russian pharmaceutical industry, and other development measures the national pharmaceutical industry could use to address expanding access to and the variety of available medicines, drug list planning, deficit prevention, and other topical issues.
The Drug Security Forum is organized by the Roscongress Foundation and the Content Foundation for Expertise and Analysis. The Forum is organized with the support of the Ministry of Health of the Russian Federation and the Subcommittee on the Circulation of Medicines and Pharmaceutical and Medical Industry Development, part of the Committee on Health Protection of the State Duma of the Russian Federation.
The session is held with the support of Pharmasyntez Group.
Official Drug Security Forum website: pharmforum.org